Last checked at 20 Jan 2022 09:01
LONDON MARKET OPEN: Glaxo down as Unilever refuses to up consumer bid
LONDON MARKET OPEN: Glaxo down as Unilever refuses to up consumer bid
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News2
GSK Share
Chat1
GSK Share
Trades1,108
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,653.50
Bid:
1,653.50
Ask:
1,654.00
Change:
2.50 (0.15%)
Spread:
0.50 (0.03%)
Open:
1,656.50
High:
1,661.50
Low:
1,652.00
Prev. Close:
1,651.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.20 Jan 2022 08:50
UPDATE 3-Unilever strategy under scrutiny after short-lived GSK skirmish
* Unilever closes down 0.7%, GSK shares slip 2%* Analysts largely positive on Unilever decision* Questions over CEO Alan Jope's strategy remain (Adds details from new Terry Smith letter; updates shares)By Pushkala AripakaJan 20 (Reuters) - Unilever'...
Read more20 Jan 2022 08:50
UPDATE 2-Unilever's strategy in spotlight after dropping $68 billion GSK battle
* Unilever gains 2%, GSK shares slip* Analysts largely positive on Unilever decision* Questions over boss Alan Jope's strategy remain (Recasts with investor, analyst comments)By Pushkala AripakaJan 20 (Reuters) - Unilever's strategy was under the i...
Read more19 Jan 2022 17:17
Unilever failed bid for GSK unit reveals pain of sustainability shift
Unilever failed bid for GSK unit reveals pain of sustainability shift
Read more19 Jan 2022 16:55
TOP NEWS: Unilever decides against sweetening GSK consumer arm bid
TOP NEWS: Unilever decides against sweetening GSK consumer arm bid
Read more19 Jan 2022 16:49
CORRECTED-UPDATE 3- Unilever will not raise rejected 50 bln pound bid for GSK consumer arm
(Corrects JAN 19 story to make clear Pfizer has stake in consumer healthcare business, paragraph 6)Jan 19 (Reuters) - Unilever PLC on Wednesday effectively abandoned its plans to buy GlaxoSmithKline's consumer healthcare business, saying that it w...
Read more19 Jan 2022 16:49
UPDATE 3- Unilever will not raise rejected 50 bln pound bid for GSK consumer arm
(Adds details on GSK's financial assumptions, Pfizer stake)Jan 19 (Reuters) - Unilever PLC on Wednesday effectively abandoned its plans to buy GlaxoSmithKline's consumer healthcare business, saying that it would not raise its 50 billion pound ($6...
Read more19 Jan 2022 16:49
UPDATE 2-Unilever will not increase 50-billion-pound offer for GSK consumer arm
(Adds GSK comment, details on offer, shares)Jan 19 (Reuters) - Unilever PLC on Wednesday effectively abandoned its plans to buy GlaxoSmithKline's consumer healthcare business, saying on Wednesday that it would not raise a 50 billion pound ($68 bi...
Read more19 Jan 2022 16:45
Unilever won't lift £50bn offer for GSK consumer health arm
(Sharecast News) - Unilever will not be increasing its offer for GlaxoSmithKline's consumer healthcare business.
Read more19 Jan 2022 10:26
GlaxoSmithKline promotes internally as chief scientist set for US move
GlaxoSmithKline promotes internally as chief scientist set for US move
Read more19 Jan 2022 09:29
UPDATE 2-FTSE 100 jumps on mining boost, Burberry's strong forecast
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Burberry expects annual profit to beat expectations* Pearson raises full-year operating profit forecasts* UK's December CPI jumps to 30-yea...
Read more19 Jan 2022 09:02
GSK chief science officer leaves to join US startup
(Sharecast News) - GlaxoSmithKline said it had appointed Tony Wood as chief scientific officer designate after Hall Barron said he was resigning the post to run a new privately owned start-up biotech company. .
Read more19 Jan 2022 08:29
UPDATE 1-GSK chief scientist Barron to leave for U.S. biotech start-up
(Adds details)LONDON, Jan 19 (Reuters) - GlaxoSmithKline's chief scientific officer Hal Barron is leaving in August, the British drugmaker said on Wednesday, moving to run a new privately-owned biotech start-up.Barron's landmark deals since joinin...
Read more19 Jan 2022 07:41
CORRECTED-GSK chief scientist Barron to leave for U.S. biotech start-up
(Correcting first name to Hal, not Hall)LONDON, Jan 19 (Reuters) - GlaxoSmithKline said on Wednesday that Hal Barron will end his position as chief scientific officer in August after less than five years to run a new privately owned start-up biote...
Read more19 Jan 2022 07:41
GSK chief scientist Barron to leave for U.S. biotech start-up
LONDON, Jan 19 (Reuters) - GlaxoSmithKline said on Wednesday that Hall Barron will end his position as chief scientific officer in August after less than five years to run a new privately owned start-up biotech company.Tony Wood will become CSO de...
Read more